Related Experiment Video
Updated: Nov 28, 2025

Live Imaging and Quantification of Viral Infection in K18 hACE2 Transgenic Mice Using Reporter-Expressing Recombinant SARS-CoV-2
Published on: November 5, 2021
SARS-CoV-2 Aiming for the Heart: A Multicenter Italian Perspective About Cardiovascular Issues in COVID-19
Matteo Briguglio1, Mauro Porta2, Francesca Zuffada3
1IRCCS Orthopedic Institute Galeazzi, Scientific Direction, Milan, Italy.
Insights
Coronavirus disease 2019 (COVID-19) causes severe cardiovascular complications, including myocardial injury and thrombosis. Understanding these cardiac effects is crucial for developing effective treatments for COVID-19 patients.
Area of Science:
- Cardiology
- Infectious Diseases
- Pathophysiology
Background:
- The global impact of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease 2019 (COVID-19) continues to strain healthcare systems worldwide.
- COVID-19 presents with unpredictable symptoms, often exacerbated by advanced age, malnutrition, and cardiovascular comorbidities.
- The virus primarily affects the lungs but can lead to fatal cardiovascular consequences in susceptible individuals.
Purpose of the Study:
- To elucidate the pathophysiology of COVID-19 from a cardiological perspective.
- To highlight the major cellular and clinical manifestations of COVID-19 affecting the cardiovascular system.
- To emphasize the importance of a cardiology-focused approach to understanding and managing COVID-19.
Main Methods:
- Review of current literature on SARS-CoV-2 infection and its cardiovascular implications.
- Analysis of cellular mechanisms and clinical presentations of cardiac involvement in COVID-19.
- Emphasis on the cardiological perspective of viral transmission and its effects.
Main Results:
- SARS-CoV-2 can induce myocardial injuries, vasculitis-like syndromes, and atherothrombotic events.
- Electrocardiogram abnormalities may indicate pericardial effusion or cardiac inflammation.
- Microthrombi can lead to ischemic damage, stroke, and autonomic dysfunction.
Conclusions:
- COVID-19 presents significant cardiovascular challenges, including arrhythmias, coronary syndromes, and thrombotic events.
- Tailored cardiological interventions are essential for managing reduced ejection fraction, autonomic dysfunction, and thrombosis.
- Further research and global assessment of therapeutic strategies are needed for effective evidence-based treatments.
Abstract:
The rapid spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and the high fatality rate of coronavirus disease 2019 (COVID-19) have been putting a strain on the world since December 2019. Infected individuals exhibit unpredictable symptoms that tend to worsen if age is advanced, a state of malnutrition persists, or if cardiovascular comorbidities are present. Once transmitted, the virus affects the lungs and in predisposed individuals can elicit a sequela of fatal cardiovascular consequences. We aim to present the pathophysiology of COVID-19, emphasizing the major cellular and clinical manifestations from a cardiological perspective. As a roaming viral particle or more likely via the Trojan horse route, SARS-CoV-2 can access different parts of the body. Cardiovascular features of COVID-19 can count myocardial injuries, vasculitis-like syndromes, and atherothrombotic manifestations. Deviations in the normal electrocardiogram pattern could hide pericardial effusion or cardiac inflammation, and dispersed microthrombi can cause ischemic damages, stroke, or even medullary reflex dysfunctions. Tailored treatment for reduced ejection fraction, arrhythmias, coronary syndromes, macrothrombosis and microthrombosis, and autonomic dysfunctions is mandatory. Confidently, evidence-based therapies for this multifaceted nevertheless purely cardiological COVID-19 will emerge after the global assessment of different approaches.
More Related Videos
Related Concept Videos
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Coronary Artery Disease II: Pathophysiology
Coronary Artery Disease III: Clinical Manifestations
Psychoneuroimmunology: Cardiovascular Disease
A key area of focus in PNI is the relationship between stress and coronary...
Coronary Artery Disease I: Introduction
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

